Sleep Aids - Americas

Americas

Highlights

Revenue in the Sleep Aids market amounts to US$2.35bn in 2024. The market is expected to grow annually by 3.71% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$2bn in 2024).
In relation to total population figures, per person revenues of US$2.31 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Sleep Aids market in Americas is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in the Americas are increasingly prioritizing their sleep quality and are willing to invest in sleep aids to improve their overall well-being. The fast-paced lifestyle and high-stress levels in the region have led to a rise in sleep disorders, such as insomnia and sleep apnea. As a result, there is a growing demand for sleep aids that can help individuals fall asleep faster, stay asleep longer, and wake up feeling refreshed.

Trends in the market: One of the key trends in the Sleep Aids market in Americas is the shift towards natural and non-habit forming sleep aids. Customers are becoming more conscious about the potential side effects and dependency associated with traditional sleep medications. As a result, there is a growing demand for natural sleep aids, such as herbal supplements, aromatherapy products, and relaxation techniques. Additionally, technological advancements have led to the development of innovative sleep aids, including smart mattresses, sleep tracking devices, and sleep apps, which are gaining popularity among tech-savvy customers.

Local special circumstances: The Sleep Aids market in Americas is also influenced by local special circumstances. For instance, the United States has a large aging population, which is more prone to sleep disorders. This demographic factor has contributed to the growth of the sleep aids market in the country. In addition, the increasing prevalence of chronic diseases, such as obesity and diabetes, has also led to a higher demand for sleep aids in the region. Furthermore, the legalization of cannabis in some parts of the Americas has opened up opportunities for the development of sleep aids containing CBD, a non-psychoactive compound found in cannabis.

Underlying macroeconomic factors: Several underlying macroeconomic factors are driving the growth of the Sleep Aids market in Americas. The region has a high disposable income, which enables customers to afford premium sleep aids and invest in their sleep health. Furthermore, the increasing awareness about the importance of sleep and its impact on overall health has led to a higher willingness to spend on sleep aids. Additionally, the expanding e-commerce sector in the Americas has made it easier for customers to access a wide range of sleep aids and compare prices, contributing to market growth. In conclusion, the Sleep Aids market in Americas is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customers are increasingly prioritizing their sleep quality and seeking natural and non-habit forming sleep aids. The region's aging population, prevalence of chronic diseases, and the legalization of cannabis have also contributed to market growth. Furthermore, the high disposable income and increasing awareness about sleep health have fueled the demand for sleep aids in the Americas.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.